Subtopic Deep Dive

Quinone Derivatives as Anticancer Agents
Research Guide

What is Quinone Derivatives as Anticancer Agents?

Quinone derivatives are redox-active compounds derived from quinone scaffolds, such as naphthoquinones like shikonin and mitomycin analogs, evaluated for anticancer activity through mechanisms including apoptosis induction and DT-diaphorase modulation.

Research focuses on synthesis and preclinical testing of quinone-based agents from natural sources like Chinese herbs and marine organisms to target tumors. Key examples include shikonin from Lithospermum erythrorhizon (Andújar et al., 2013, 281 citations) and compounds influencing DT-diaphorase (Kelland et al., 1999, 350 citations). Over 10 major reviews document their anti-proliferative and pro-apoptotic effects (Pfeffer and Singh, 2018, 1502 citations).

15
Curated Papers
3
Key Challenges

Why It Matters

Quinone derivatives like shikonin inhibit tumor proliferation and induce apoptosis via caspase activation, offering leads for solid tumor chemotherapy (Pfeffer and Singh, 2018). Shikonin from traditional Chinese medicine shows efficacy against multidrug-resistant cancers by redox cycling and DT-diaphorase dependency (Andújar et al., 2013; Kelland et al., 1999). Marine quinones provide novel structures for overcoming resistance, as cataloged in pharmacological reviews (Mayer et al., 2013). These agents enhance natural product-based drug discovery, with Chinese herb extracts suppressing angiogenesis and metastasis (Tan et al., 2011).

Key Research Challenges

Overcoming Multidrug Resistance

Tumor cells evade quinone cytotoxicity through upregulated efflux pumps and altered redox enzymes like DT-diaphorase (Kelland et al., 1999). Derivatives must balance efficacy against resistant lines while minimizing normal cell toxicity. Preclinical models show variable sensitivity tied to NQO1 polymorphism.

Redox Toxicity Management

Quinones generate reactive oxygen species, causing off-target damage in cardiac and hepatic tissues (Andújar et al., 2013). Structure optimization aims to enhance tumor-selective reduction without systemic oxidative stress. Natural extracts complicate isolation of active quinone synergies (Caesar and Cech, 2019).

Scalable Synthesis from Naturals

Low yields from marine and herbal sources hinder clinical translation of quinone leads (Mayer et al., 2013; Tan et al., 2011). Synthetic analogs require preserving bioactivity amid modifications for stability. Biodiversity-driven discovery demands efficient analog libraries.

Essential Papers

1.

Apoptosis: A Target for Anticancer Therapy

Claire M. Pfeffer, Amareshwar T.K. Singh · 2018 · International Journal of Molecular Sciences · 1.5K citations

Apoptosis, the cell’s natural mechanism for death, is a promising target for anticancer therapy. Both the intrinsic and extrinsic pathways use caspases to carry out apoptosis through the cleavage o...

2.

Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2

Lindsay K. Caesar, Nadja B. Cech · 2019 · Natural Product Reports · 730 citations

This report documents the cellular, molecular, and analytical methods used to identify combination effects in complex natural product mixtures.

3.

Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine

Hua Luo, Chi Teng Vong, Hanbin Chen et al. · 2019 · Chinese Medicine · 549 citations

4.

Marine Pharmacology in 2009–2011: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis, and Antiviral Activities; Affecting the Immune and Nervous Systems, and other Miscellaneous Mechanisms of Action

Alejandro M. S. Mayer, Abimael D. Rodrı́guez, Orazio Taglialatela‐Scafati et al. · 2013 · Marine Drugs · 430 citations

The peer-reviewed marine pharmacology literature from 2009 to 2011 is presented in this review, following the format used in the 1998–2008 reviews of this series. The pharmacology of structurally-c...

5.

Anti-cancer natural products isolated from chinese medicinal herbs

Wen Tan, Jin‐Jian Lu, Mingqing Huang et al. · 2011 · Chinese Medicine · 394 citations

Abstract In recent years, a number of natural products isolated from Chinese herbs have been found to inhibit proliferation, induce apoptosis, suppress angiogenesis, retard metastasis and enhance c...

6.

Imidazoles as potential anticancer agents

Imran Ali, Mohammad Nadeem Lone, H. Y. Aboul‐Enein · 2017 · MedChemComm · 387 citations

Cancer is a black spot on the face of humanity in this era of science and technology.

7.

DT-Diaphorase Expression and Tumor Cell Sensitivity to 17-Allylamino,17-demethoxygeldanamycin, an Inhibitor of Heat Shock Protein 90

LR Kelland, Swee Y. Sharp, Paul Rogers et al. · 1999 · JNCI Journal of the National Cancer Institute · 350 citations

These results suggest that the antitumor activity and possibly the toxicologic properties of 17AAG in humans may be influenced by the expression of DT-diaphorase. Careful monitoring for NQO1 polymo...

Reading Guide

Foundational Papers

Start with Andújar et al. (2013) for shikonin pharmacology basics, then Kelland et al. (1999) for DT-diaphorase mechanisms, and Mayer et al. (2013) for marine quinone diversity, providing structural and activity foundations.

Recent Advances

Pfeffer and Singh (2018, 1502 citations) on apoptosis targeting; Caesar and Cech (2019, 730 citations) on natural product synergies; Luo et al. (2019, 549 citations) on Chinese herb quinones.

Core Methods

Core techniques: Redox cycling assays via DT-diaphorase (NQO1) expression; apoptosis via caspase Western blots; synergy indexing in extracts (Caesar and Cech, 2019); preclinical xenografts (Tan et al., 2011).

How PapersFlow Helps You Research Quinone Derivatives as Anticancer Agents

Discover & Search

Research Agent uses searchPapers and exaSearch to find 250+ papers on 'quinone derivatives shikonin anticancer', then citationGraph on Andújar et al. (2013) reveals 281-cited connections to DT-diaphorase works like Kelland et al. (1999), while findSimilarPapers expands to marine quinones (Mayer et al., 2013).

Analyze & Verify

Analysis Agent applies readPaperContent to extract DT-diaphorase mechanisms from Kelland et al. (1999), verifies claims with CoVe against Pfeffer and Singh (2018) apoptosis data, and runs PythonAnalysis for dose-response stats from shikonin assays using NumPy/pandas, graded by GRADE for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in resistance-overcoming quinone derivatives via contradiction flagging across Tan et al. (2011) and Caesar and Cech (2019), then Writing Agent uses latexEditText, latexSyncCitations for Andújar et al. (2013), and latexCompile to generate review sections with exportMermaid redox pathway diagrams.

Use Cases

"Analyze IC50 trends for shikonin derivatives across cancer cell lines from 10 papers."

Research Agent → searchPapers('shikonin IC50 cancer') → Analysis Agent → readPaperContent(Andújar 2013) + runPythonAnalysis(pandas aggregation of dose-response data) → matplotlib plots of resistance correlations.

"Draft LaTeX review on marine quinone antitumor agents with citations."

Research Agent → exaSearch('marine quinones anticancer') → Synthesis Agent → gap detection → Writing Agent → latexEditText(structured outline) → latexSyncCitations(Mayer 2013) → latexCompile(PDF with figures).

"Find GitHub repos with quinone synthesis simulations or QSAR models."

Research Agent → searchPapers('quinone derivatives QSAR anticancer') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → exportCsv of modeling scripts for DT-diaphorase predictions.

Automated Workflows

Deep Research workflow scans 50+ papers on quinone apoptosis (Pfeffer 2018 start), chains citationGraph → findSimilarPapers → structured report on shikonin efficacy. DeepScan applies 7-step CoVe to verify DT-diaphorase claims (Kelland 1999) with GRADE checkpoints. Theorizer generates hypotheses on quinone synergies from Caesar and Cech (2019) natural extracts.

Frequently Asked Questions

What defines quinone derivatives as anticancer agents?

Quinone derivatives feature a cyclic dione structure enabling redox cycling, like shikonin and mitomycin analogs, which generate ROS to trigger apoptosis in tumors (Andújar et al., 2013; Pfeffer and Singh, 2018).

What are key methods for evaluating quinones?

Methods include DT-diaphorase activity assays for sensitivity, caspase activation for apoptosis, and xenograft models for efficacy, as in Kelland et al. (1999) and Tan et al. (2011).

What are major papers on this topic?

Foundational works: Andújar et al. (2013, 281 citations) on shikonin; Kelland et al. (1999, 350 citations) on DT-diaphorase; Mayer et al. (2013, 430 citations) on marine quinones.

What open problems exist?

Challenges include selective toxicity, scalable synthesis from naturals, and overcoming resistance via efflux pumps, unaddressed in current extracts (Caesar and Cech, 2019; Kelland et al., 1999).

Research Bioactive Compounds and Antitumor Agents with AI

PapersFlow provides specialized AI tools for Pharmacology, Toxicology and Pharmaceutics researchers. Here are the most relevant for this topic:

See how researchers in Life Sciences use PapersFlow

Field-specific workflows, example queries, and use cases.

Life Sciences Guide

Start Researching Quinone Derivatives as Anticancer Agents with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Pharmacology, Toxicology and Pharmaceutics researchers